A team of researchers at UCLA Health Jonsson Comprehensive Cancer Center has identified a potential new strategy to prevent, and potentially reverse, immune checkpoint inhibitor (ICI)–induced type I ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback